(Q41688205)

7 October 2017

C1qB and clusterin mRNA increase in association with neurodegeneration in sporadic amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

7 October 2017

0 references

1 reference

Grewal RP

1

1 reference

7 October 2017

Morgan TE

series ordinal

2

1 reference

7 October 2017

Finch CE

series ordinal

3

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

7 October 2017

1 reference

7 October 2017

271

1 reference

7 October 2017

1

1 reference

7 October 2017

65-67

1 reference

Human gliomas and epileptic foci express high levels of a mRNA related to rat testicular sulfated glycoprotein 2, a purported marker of cell death

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Inflammatory cells in the peripheral nervous system in motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Complement and clusterin in the spinal cord dorsal horn and gracile nucleus following sciatic nerve injury in the adult rat

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Distribution of clusterin in Alzheimer brain tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Complement C1qB and C4 mRNAs responses to lesioning in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Amyotrophic lateral sclerosis: theories and therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Cerebrospinal fluid interleukin 6 in amyotrophic lateral sclerosis: immunological parameter and comparison with inflammatory and non-inflammatory central nervous system diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

The genetic and molecular mechanisms of motor neuron disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2899%2900496-6

7 January 2021

10.1016/S0304-3940(99)00496-6

Identifiers

DOI

1 reference

7 October 2017

1 reference